|
Synonyms: AP-12009 | OT-101
Compound class:
Nucleic acid
Comment: Trabedersen (OT-101) is an 18-mer phosphorothioate antisense oligonucleotide (ASO) that targets transforming growth factor-beta 2 (TGF-β2) mRNA to reduce receptor synthesis. This mechanism is intended for application in cancer therapy.
|
|
|||||||||||||||||
| Immunopharmacology Comments |
| TGF-β2 plays a crucial role in tumour immune evasion and progression. Targeted reduction of protein synthesis is proposed as a mechanism to treat multiple cancer types by reprogramming the tumour microenvironment; converting immunosuppressive macrophages into pro-inflammatory macrophages that enhance anti-tumour immunity. |